Structural Insights into Notch Receptor-Ligand Interactions

被引:13
|
作者
Handford, Penny A. [1 ]
Korona, Boguslawa [1 ]
Suckling, Richard [2 ]
Redfield, Christina [1 ]
Lea, Susan M. [2 ]
机构
[1] Univ Oxford, Dept Biochem, Oxford OX1 3RE, England
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
来源
基金
英国医学研究理事会;
关键词
EGF12; Calcium binding; Fringe; C2; domain; Lipid binding; FACTOR-LIKE REPEATS; O-LINKED FUCOSE; CALCIUM-BINDING; EXTRACELLULAR DOMAIN; FRINGE; GLYCOSYLATION; DELTA; ELONGATION; EXPRESSION; MUTATIONS;
D O I
10.1007/978-3-319-89512-3_2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pioneering cell aggregation experiments from the Artavanis-Tsakonas group in the late 1980's localized the core ligand recognition sequence in the Drosophila Notch receptor to epidermal growth factor-like (EGF) domains 11 and 12. Since then, advances in protein expression, structure determination methods and functional assays have enabled us to define the molecular basis of the core receptor/ligand interaction and given new insights into the architecture of the Notch complex at the cell surface. We now know that Notch EGF11 and 12 interact with the Delta/Serrate/LAG-2 (DSL) and C2 domains of ligand and that membrane-binding, together with additional protein-protein interactions outside the core recognition domains, are likely to fine-tune generation of the Notch signal. Furthermore, structure determination of O-glycosylated variants of Notch alone or in complex with receptor fragments, has shown that these sugars contribute directly to the binding interface, as well as to stabilizing intra-molecular domain structure, providing some mechanistic insights into the observed modulatory effects of O-glycosylation on Notch activity. Future challenges lie in determining the complete extracellular architecture of ligand and receptor in order to understand (i) how Notch/ligand complexes may form at the cell surface in response to physiological cues, (ii) the role of lipid binding in stabilizing the Notch/ligand complex, (iii) the impact of O-glycosylation on binding and signalling and (iv) to dissect the different pathologies that arise as a consequence of mutations that affect proteins involved in the Notch pathway.
引用
收藏
页码:33 / 46
页数:14
相关论文
共 50 条
  • [21] ReLiBase - A DATABASE FOR ANALYSING RECEPTOR-LIGAND INTERACTIONS
    Hendlich, Manfred
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 71 - 71
  • [22] Kinetics of Receptor-Ligand Interactions in Immune Responses
    Long, Mian
    Lu, Shouqin
    Sun, Ganyun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2006, 3 (02) : 79 - 86
  • [23] Solving inconsistencies in the analysis of receptor-ligand interactions
    Tuk, B
    vanOostenbruggen, MF
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (11) : 403 - 409
  • [24] Mutational analysis of receptor-ligand interactions in the opioid system
    Hjorth, SA
    Schwartz, TW
    STRUCTURE AND FUNCTION OF 7TM RECEPTORS, 1996, 39 : 303 - 314
  • [25] Quantifying Rosette Formation Mediated by Receptor-ligand Interactions
    Mian LONG(National Microgravity Laboratory
    生物医学工程学杂志, 2005, (S1) : 35 - 36
  • [26] Mycobacterial Adhesion: From Hydrophobic to Receptor-Ligand Interactions
    Viljoen, Albertus
    Dufrene, Yves F.
    Nigou, Jerome
    MICROORGANISMS, 2022, 10 (02)
  • [27] Modelling of ORL1 receptor-ligand interactions
    Sencanski, Milan
    Ivanovic, Milovan D.
    Dosen-Micovic, Ljiljana
    CHEMICAL PAPERS, 2014, 68 (10): : 1305 - 1316
  • [28] Matrix mechanics and receptor-ligand interactions in cell adhesion
    Harjanto, Dewi
    Zaman, Muhammad H.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (02) : 299 - 304
  • [29] A BW Reporter System for Studying Receptor-Ligand Interactions
    Elias, Shlomo
    Kahlon, Shira
    Duev-Cohen, Alexandra
    Mandelboim, Ofer
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (143):
  • [30] Receptor-ligand interactions in a reconstituted bilayer lipid membrane
    Wang, L
    Hou, XP
    Ottova, A
    Tien, HT
    ELECTROCHEMISTRY COMMUNICATIONS, 2000, 2 (05) : 287 - 289